BCAL Diagnostics Ltd (BDX)

Sydney

Currency in AUD

0.08

0.00(0.00%)

Closed·11/09

Fair Value

Unlock Value

Day's Range

0.07

0.08

52 wk Range

0.05

0.15

BDX Income Statement

Featured here, the Income Statement (earnings report) for BCAL Diagnostics Ltd, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Period Ending:

2018

30/06

2019

30/06

2020

30/06

2021

30/06

2022

30/06

2023

30/06

2024

30/06

2025

30/06

2026

30/06

Total Revenues

aa.aa

0.72

2.79

3.05

2.65

2.35

Total Revenues Growth

aa.aa

+161.09%

+288.29%

+9.18%

-13.01%

-11.25%

Cost Of Revenues

aa.aa

Gross Profit

aa.aa

0.72

2.79

3.05

2.65

2.35

Gross Profit Growth

aa.aa

+161.09%

+288.29%

+9.18%

-13.01%

-11.25%

Gross Profit Margin %

aa.aa

100%

Other Operating Expenses, Total

aa.aa

3.77

7.58

9.13

9.77

9.42

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	+211.52%	+101.18%	+20.42%	+7.1%	-3.59%
aa.aa	aa.aa	aa.aa	aa.aa	1.91	4.47	4.36	4.46	4.67
aa.aa	aa.aa	aa.aa	aa.aa	1.83	2.99	4.18	4.31	4.03
aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

-3.05

-4.79

-6.08

-7.12

-7.07

Operating Income Growth

aa.aa

-226.38%

-57.06%

-26.97%

-17.17%

+0.74%

EBIT Margin %

aa.aa

-424.13%

-171.55%

-199.51%

-268.73%

-300.54%

Net Interest Expenses

aa.aa

0.05

-0.05

0.09

-0.31

Net Interest Expenses Growth

aa.aa

-205.25%

+290.78%

-436.98%

Interest Expense, Total

aa.aa

-0.02

-0.1

-0.09

-0.35

Interest And Investment Income

aa.aa

0.06

0.05

0.18

0.03

Other Non Operating Expenses, Total

aa.aa

-0.34

-0.32

-0.27

-0.21

-0.15

EBT, Excl. Unusual Items

aa.aa

-3.39

-5.06

-6.4

-7.24

-7.53

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

EBT, Incl. Unusual Items

aa.aa

-3.39

-5.06

-6.4

-7.24

-7.37

EBT, Incl. Unusual Items Growth

aa.aa

-122%

-49.51%

-26.44%

-13.14%

-1.8%

EBT, Incl. Unusual Items Margin

aa.aa

-471.08%

-181.39%

-210.07%

-273.21%

-313.39%

Income Tax Expense

aa.aa

Net Income to Company

aa.aa

-3.39

-5.06

-6.4

-7.24

-7.37

Minority Interest

aa.aa

Net Income

aa.aa

-3.39

-5.06

-6.4

-7.24

-7.37

Net Income Growth

aa.aa

-122%

-49.51%

-26.44%

-13.14%

-1.8%

Net Income Margin %

aa.aa

-471.08%

-181.39%

-210.07%

-273.21%

-313.39%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-3.39

-5.06

-6.4

-7.24

-7.37

Basic EPS - Continuing Operations

aa.aa

-0.02

-0.03

-0.02

Basic EPS - Continuing Operations Growth

aa.aa

-46.4%

-44.82%

-8.3%

+22.53%

+0.4%

Diluted EPS - Continuing Operations

aa.aa

-0.02

-0.03

-0.02

Diluted EPS - Continuing Operations Growth

aa.aa

-46.63%

-44.59%

-8.33%

+22.55%

+0.4%

Basic Weighted Average Shares Outstanding

aa.aa

204.29

210.9

246.23

359.6

367.56

Diluted Weighted Average Shares Outstanding

aa.aa

204.29

210.9

246.23

359.6

367.56

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-3.03

-4.73

-5.73

-6.39

-6.59

EBITDA Growth

aa.aa

-226.88%

-56.19%

-21.24%

-11.5%

-3.1%

EBITDA Margin %

aa.aa

-421.26%

-169.45%

-188.17%

-241.18%

-280.16%

EBIT

aa.aa

-3.05

-4.79

-6.08

-7.12

-7.07

* In Millions of AUD (except for per share items)

FAQ

What was BCAL Diagnostics’s revenue at year end?

At the end of the last reported fiscal year, BCAL Diagnostics (BDX) recorded total revenue of 2.35 million AUD.

How much revenue did BCAL Diagnostics report in the most recent quarter?

In its most recent quarterly earnings report, BCAL Diagnostics posted revenue of 1.08 million AUD.

What was BCAL Diagnostics’s net income for the year?

For the full year, BCAL Diagnostics reported net income of -7.37 million AUD.

How much net income did BCAL Diagnostics post in the last quarter?

In the most recent quarter, BCAL Diagnostics (BDX) posted net income of -3.45 million AUD.

What was BCAL Diagnostics’s gross profit for the year?

Gross profit for the year was reported at 2.35 million AUD.

How much gross profit did BCAL Diagnostics generate last quarter?

BCAL Diagnostics recorded gross profit of 1.08 million AUD in its latest quarterly report.

What was BCAL Diagnostics’s annual operating income?

For the full year, BCAL Diagnostics (BDX) reported operating income of -7.07 million AUD.

What was BCAL Diagnostics’s operating income last quarter?

Quarterly operating income was -3.38 million AUD.

What was BCAL Diagnostics’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -3.30 million AUD.

What was the quarter-over-quarter change in EBITDA for BCAL Diagnostics?

EBITDA changed by -0.07% million AUD compared to the last quarter.

What is BCAL Diagnostics’s most recent net income margin?

Net income margin based on recent financials is -319.94% million AUD.

What is BCAL Diagnostics’s most recent EBIT margin?

BCAL Diagnostics reported an EBIT margin of -313.41% million AUD based on current figures.

How did BCAL Diagnostics’s revenue change compared to the previous quarter?

Revenue changed by -15.17% million AUD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for BCAL Diagnostics?

In the latest quarter, gross profit changed by -15.17% million AUD from the previous quarter.

NSE 30

8,940.99

+20.16

+0.23%

NSE All Share

243,052.73

+674.61

+0.28%

US 30

52,562.50

+498.0

+0.96%

US 500

7,657.40

+65.6

+0.86%

FTSE 100

10,650.44

+41.52

+0.39%

DAX

25,568.56

+207.41

+0.82%

South Africa Top 40

107,759.48

+207.50

+0.19%

Market Movers

Name	Last	Chg. %	Vol.
Aradel Holdings	1,414.00	+0.07%	3.64M
Guaranty Trust Holding	129.80	-0.08%	29.48M
MTN Nigeria	811.10	-0.23%	3.52M
Seplat Petroleum	14,907.80	0.00%	105.33K
STANBIC IBTC Bank	152.90	-1.58%	9.16M
Fidelitybk	19.000	+1.60%	67.57M
Zenith Bank	125.30	+0.64%	9.77M

Name	Last	Chg. %	Vol.
Abbey Mortgage Bank	7.15	+10.00%	559.38K
UPDC REIT	13.75	+10.00%	1.65M
Omatek Ventures	1.37	+9.60%	1.96M
Consolidated Hallmark	6.50	+9.06%	5.87M
Chams	3.67	+8.90%	13.00M
Etranz	13.000	+8.79%	494.33K
International Breweries	10.00	+8.70%	2.84M

Name	Last	Chg. %	Vol.
John Holt PLC	9.00	-10.00%	116.40K
Austin Laz	1.99	-9.55%	663.37K
Royalex	0.90	-9.09%	870.09K
UPDC	3.20	-5.88%	673.14K
Secure Electronic Tech	0.65	-4.41%	10.72M
Critical	2.00	-4.31%	5.60M
Academy Press	5.20	-3.70%	512.08K

Trending Stocks

Name	Last	Chg. %	Vol.
MTN Nigeria	811.10	-0.23%	3.52M
Nigerian Exchange	148.00	+8.03%	2.99M
Jaiz Bank	8.10	+3.85%	6.78M
Initiates	24.20	+2.98%	3.67M
First HoldCo	136.00	0.00%	8.07M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaa Aaa	17.600	+38.03%	24.293
Aaaa Aaaaaaa A Aa	384.80	+30.83%	503.43
Aaaaaa Aa	74.00	+30.37%	96.47
Aaaaaaaaaaaaa Aaaa	1,034.00	+19.48%	1,235.42
Aaaa A A Aaa Aaaa	58.45	+19.45%	69.82
Aaa Aaaaaaaaaaaaa	34.50	+14.81%	39.61
Aaaaaaaa Aaaaaaaa	10.45	+13.25%	11.83

Name	Last	Upside	Fair Value
Aaaaaaa Aaa	17.600	+38.03%	24.293
Aaaa Aaaaaaa A Aa	384.80	+30.83%	503.43
Aaaaaa Aa	74.00	+30.37%	96.47
Aaaaaaaaaaaaa Aaaa	1,034.00	+19.48%	1,235.42
Aaaa A A Aaa Aaaa	58.45	+19.45%	69.82
Aaa Aaaaaaaaaaaaa	34.50	+14.81%	39.61
Aaaaaaaa Aaaaaaaa	10.45	+13.25%	11.83

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

BCAL Diagnostics Ltd (BDX)

BDX Income Statement

FAQ

What was BCAL Diagnostics’s revenue at year end?

How much revenue did BCAL Diagnostics report in the most recent quarter?

What was BCAL Diagnostics’s net income for the year?

How much net income did BCAL Diagnostics post in the last quarter?

What was BCAL Diagnostics’s gross profit for the year?

How much gross profit did BCAL Diagnostics generate last quarter?

What was BCAL Diagnostics’s annual operating income?

What was BCAL Diagnostics’s operating income last quarter?

What was BCAL Diagnostics’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for BCAL Diagnostics?

What is BCAL Diagnostics’s most recent net income margin?

What is BCAL Diagnostics’s most recent EBIT margin?

How did BCAL Diagnostics’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for BCAL Diagnostics?

Trending Stocks